Anti-snoring Devices And Snoring Surgery Market Size, Trends, Share, Growth | Report 2022-2030

The global anti-snoring devices and snoring surgery market size was estimated at around USD 1.45 billion in 2021 and it is projected to hit around USD 2.8 billion by 2030, growing at a CAGR of 7.59% from 2022 to 2030.

Increasing focus on developing new products in the market by the key players is expected to boost the growth of the market. In addition, the ever-rising cases of snoring issues and sleep apnea are also expected to propel the growth of the market over the forecast period. For instance, according to the American Sleep Association, about 50-70 million U.S. adults have a sleep disorder and 48% of this report snoring.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39261

Various restrictions laid down by the government as an attempt to curb the spread of the COVID-19 virus led to a major loss across the majority of industries. While the restriction on traveling and movement led to a major disruption in the supply of products and services, it also led to reduced patient visits to the hospitals and clinics. Thus, the pandemic had a huge impact on the healthcare industry. The global market felt a slight yet significant negative impact too. The reduced patient visits to the hospitals and clinics further led to a reduced number of patients seeking treatment for snoring. However, with the world returning to normalcy and manufacturers focusing on new and advanced product development, the market is expected to experience considerable growth over the forecast period.

Scope of The Report

Type Insights

Based on type, the market is segmented into oral appliances/mouthpieces, nasal devices, position control devices, chin straps, tongue stabilizing devices, and EPAP therapy devices. The oral appliances/mouthpieces segment dominated the global market with a revenue share of 29.83% in 2021. Factors, such as growing adoption of and awareness about oral appliances/mouthpieces among dentists and patients and the launch of technologically advanced products. Oral appliances/mouthpieces are also recommended as the first line of treatment, which has resulted in the higher adoption rate of these devices compared to other anti-snoring devices.

The position-control devices segment is estimated to register the fastest CAGR from 2022 to 2030. The PAP therapy devices segment was the second-leading type segment, in terms of revenue, in 2021. One of the main factors driving the growth of this segment includes the launch of new products and the manufacturers’ efforts to increase their sales by entering into a distribution agreement with strong regional distributors. In addition, the EPAP therapy devices have shown tremendous potential in treating patients with snoring issues and obstructive sleep apnea, which represents a great growth opportunity for this segment over the forecast period.

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39261

Regional Insights

North America dominated the global market in 2021 and accounted for the largest share of more than 37.5% of the global revenue. This can be attributed to a large number of individuals experiencing snoring in the U.S. For instance, an estimated 45% of adults snore occasionally, while 25% snore regularly, according to an article published by John Hopkins University in 2022. Another research article by Sleep Foundation states that an estimated 57% of men and 40% of women in the U.S. are affected by snoring issues. It also stated that even an estimated 27% of children are affected. A major factor leading to a rise in the number of individuals being affected with snoring issues in the region is growing obesity.

Obesity is a major concern, especially in the U.S., caused mainly due to the growing adoption of a sedentary lifestyle and an increase in the consumption of processed foods. Moreover, the presence of market players in this region and the availability of products on e-commerce sites as well as in retail stores will boost the market penetration and product reach. Asia Pacific is anticipated to register the fastest CAGR from 2022 to 2030. The region represents high growth due to the presence of a large pool of untreated individuals with snoring issues and the rising awareness regarding this condition. Growing disposable income levels are also expected to boost the product demand in this region.

Key Players

• Apnea Sciences Corp.
• SomnoMed Ltd.
• Airway Management, Inc.
• ResMed Inc.
• Fisher & Paykel Healthcare Corp. Ltd.
• Koninklijke Philips NV
• Sleep Well Enjoy Life, Ltd.
• TomedDr. Toussaint GmbH
• MEDiTAS Ltd.

Market Segmentation

• By Type Outlook
  • Oral Appliances/Mouthpieces
  • Nasal Devices
  • Position Control Devices
  • Chin Straps
  • Tongue Stabilizing Devices
  • EPAP Therapy Devices
• By Regional Outlook
  • North America

• • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39261

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333